Diagnostics for the Real World (Europe) Ltd (DRW Europe), a subsidiary of Diagnostics for the Real World Ltd, is a medical device company that manufactures and supplies testing and diagnostic equipment. The company offers simple amplification-based assay (SAMBA) platforms for rapid point-of-care detection of infectious diseases. Its portfolio of molecular tests including the SARS-CoV-2 test to detect the presence of the novel coronavirus; SCoV-2/Flu/RSV and SARS-CoV-2/FluA/FluB tests for qualitative detection of nucleic acids; SARS-CoV-2/RSV test for respiratory syncytial virus (RSV) in human respiratory specimens; HIV-1 Qualitative Whole Blood test for the detection of HIV-1 viral RNA and pro-viral DNA and others. The company operates in the US and the UK. DRW Europe is headquartered in Saffron Walden, England, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Diagnostics for the Real World (Europe) Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Diagnostics for the Real World (Europe) Ltd Company Overview
- Diagnostics for the Real World (Europe) Ltd Company Snapshot
- Diagnostics for the Real World (Europe) Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Diagnostics for the Real World (Europe) Ltd - Pipeline Analysis Overview
- Diagnostics for the Real World (Europe) Ltd - Key Facts
- Diagnostics for the Real World (Europe) Ltd - Major Products and Services
- Diagnostics for the Real World (Europe) Ltd Pipeline Products by Development Stage
- Diagnostics for the Real World (Europe) Ltd Pipeline Products Overview
- SAMBA - HIV-1 Viral Load Assay
- SAMBA - HIV-1 Viral Load Assay Product Overview
- SAMBA - Influenza A/B Assay
- SAMBA - Influenza A/B Assay Product Overview
- SAMBA II - Combo Test
- SAMBA II - Combo Test Product Overview
- SAMBA II - Influenza A/B Rapid Assay
- SAMBA II - Influenza A/B Rapid Assay Product Overview
- SAMBA VL
- SAMBA VL Product Overview
- SAS - Hepatitis-C Assay
- SAS - Hepatitis-C Assay Product Overview
- SAS - HIV Assay
- SAS - HIV Assay Product Overview
- SAS - Influenza A/B Rapid Test
- SAS - Influenza A/B Rapid Test Product Overview
- Diagnostics for the Real World (Europe) Ltd - Key Competitors
- Diagnostics for the Real World (Europe) Ltd - Key Employees
- Diagnostics for the Real World (Europe) Ltd - Locations And Subsidiaries
- Head Office
- Recent Developments
- Diagnostics for the Real World (Europe) Ltd, Recent Developments
- Sep 02, 2020: Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised patients
- Jan 30, 2020: Bright Machines and DRW partner to automate HIV test production
- Jun 09, 2016: Getting help to those in need: UK scientist Helen Lee receives European Inventor Award for rapid HIV test for developing countries
- Jul 22, 2014: Cambridge diagnostic tool offers on-the-spot HIV testing to millions living with HIV in Africa
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Diagnostics for the Real World (Europe) Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Diagnostics for the Real World (Europe) Ltd Pipeline Products by Equipment Type
- Diagnostics for the Real World (Europe) Ltd Pipeline Products by Indication
- Diagnostics for the Real World (Europe) Ltd, Key Facts
- Diagnostics for the Real World (Europe) Ltd, Major Products and Services
- Diagnostics for the Real World (Europe) Ltd Number of Pipeline Products by Development Stage
- Diagnostics for the Real World (Europe) Ltd Pipeline Products Summary by Development Stage
- SAMBA - HIV-1 Viral Load Assay - Product Status
- SAMBA - HIV-1 Viral Load Assay - Product Description
- SAMBA - Influenza A/B Assay - Product Status
- SAMBA - Influenza A/B Assay - Product Description
- SAMBA II - Combo Test - Product Status
- SAMBA II - Combo Test - Product Description
- SAMBA II - Influenza A/B Rapid Assay - Product Status
- SAMBA II - Influenza A/B Rapid Assay - Product Description
- SAMBA VL - Product Status
- SAMBA VL - Product Description
- SAS - Hepatitis-C Assay - Product Status
- SAS - Hepatitis-C Assay - Product Description
- SAS - HIV Assay - Product Status
- SAS - HIV Assay - Product Description
- SAS - Influenza A/B Rapid Test - Product Status
- SAS - Influenza A/B Rapid Test - Product Description
- Diagnostics for the Real World (Europe) Ltd, Key Employees
- Glossary
- Diagnostics for the Real World (Europe) Ltd Pipeline Products by Equipment Type
- Diagnostics for the Real World (Europe) Ltd Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Adaptix Ltd
- 3N Diagnostics Ltd
- A.Menarini Diagnostics Ltd
